What changed in this filing

/stocks — the workspaceLOADING

Item 3. Legal Proceedings

2022-03-01 compared with 2021-03-01 · 83 added, 58 removed, 122 unchanged (54% of the section changed)

7 unchanged sentences

David Schlanger

Chief Executive Officer and Director

Executive Chairman

Peter Anevski

President and Chief Operating Officer

Chief Executive Officer

Jennifer Bealer

Executive Vice President, Secretary and General Counsel

Lisa Greenbaum

Executive Vice President and Chief Client Officer

Executive Vice President, General Counsel and Secretary

Mark Livingston

Chief Financial Officer

Michael Sturmer

Non- Employee Directors:

Beth Seidenberg, M.D.

Chair of the Board of Directors

Lead Independent Director

Malissia Clinton

3 unchanged sentences

Executive Officers

David Schlanger has served as our Chief Executive Officer since January 2017 and on our board of directors since March 2017.

From August 2013 until September 2016, he served as the Chief Executive Officer of WebMD Health Corp., or WebMD.

David Schlanger has served as our Executive Chairman since January 2022 and on our board of directors since March 2017.

Schlanger was previously our Chief Executive Officer from January 2017 to December 2021.

From August 2013 until September 2016, he served as the Chief Executive Officer of WebMD, an online provider of information relating to health and well-being.

Prior to that, he served as the Interim Chief Executive Officer and in various other senior executive positions at WebMD and predecessor companies for more than 15 years, including as Senior Vice President, Strategic and Corporate Development and Senior Vice President, Corporate Development.

3 unchanged sentences

We believe that Mr.

Schlanger is qualified to serve on our board of directors because of his extensive experience at healthcare companies and in executive management.

Peter Anevski has served as our Chief Operating Officer since January 2017 and our President since June 2019.

Until September 2020, Mr.

Anevski also served as our Chief Financial Officer.

qualified to serve on our board of directors because of his extensive experience at healthcare companies and in executive management.

Peter Anevski has served as our Chief Executive Officer and on our board of directors since January 2022.

He previously served as our Chief Operating Officer from January 2017 to December 2021 and our President from June 2019 to December 2021.

From January 2017 to September 2020, he also served as our Chief Financial Officer.

Anevski has extensive experience managing financial functions for public companies.

4 unchanged sentences

in Accounting from Montclair State University.

Jennifer Bealer has served as our General Counsel since October 2017.

Prior to that, she was an Associate at Ropes & Gray’s nationally-ranked healthcare practice from November 2010 to October 2017, where she gained extensive expertise in providing healthcare clients with strategic, regulatory, compliance and transaction advice.

Bealer holds Bachelor of Science degrees in Biology and Psychology from the Pennsylvania State University and received her J.D.

We believe that Mr.

Anevski is qualified to serve on our board of directors because of his significant experience at healthcare companies and as a member of our executive management team.

Jennifer Bealer has served as our Executive Vice President, General Counsel and Secretary since October 2017.

Prior to that, she was an Associate at the law firm Ropes & Gray’s nationally-ranked healthcare practice from November 2010 to October 2017, where she gained extensive expertise in providing healthcare clients with strategic, regulatory, compliance and transaction advice.

Bealer holds a B.S.

in Biology and Psychology from the Pennsylvania State University and received her J.D.

from the University of Pennsylvania Law School, A.L.M from Harvard University, and Master of Bioethics from University of Pennsylvania School of Medicine.

Lisa Greenbaum has served as our Executive Vice President and Chief Client Officer since June 2019.

Prior to that, Ms.

Greenbaum spent 15 years at WebMD in various roles, including Group General Manager of Professional Services, Senior Vice President, Group Vice President, Vice President of Sales and Executive Director.

experience working for digital health and pharmaceutical companies, including HealthStream, Merck and Procter & Gamble.

Greenbaum received her B.A.

from Duke University.

Mark Livingston has served as our Chief Financial Officer since September 2020.

Previously, Mr.

Livingston had served as our Executive Vice President of Finance since May 2019.

Prior to joining that, he served as Chief Financial Officer of the international business at Scripps Network Interactive, a media company, where he worked from August 2010 to April 2018, and as Chief Financial Officer of Emerson, Reid & Company, an employee benefits wholesaler, from June 2007 to August 2010.

Livingston had served as our Executive Vice President of Finance from May 2019 to September 2020.

Prior to that, he served as Chief Financial Officer of the International Business at Scripps Network Interactive, a media company, where he worked from August 2010 to April 2018, and as Chief Financial Officer of Emerson, Reid & Company, an employee benefits wholesaler, from June 2007 to August 2010.

Previously, Mr.

Livingston has held senior financial leadership roles at WebMD Corporation and Hess Corporation.

Livingston has held senior financial leadership roles at WebMD and Hess Corporation.

Livingston received his B.S.

from Tulane University and is a licensed Certified Public Accountant.

Michael Sturmer has served as our President since January 1, 2022 and was previously Executive Vice President, Chief Growth and Strategy Officer from February 2021 to December 2021.

Sturmer has over two decades of operations, sales and strategic experience in the healthcare industry.

From September 2016 to February 2021, he was Senior Vice President of Health Services at Livongo.

Prior to that, Mr.

Sturmer held several senior positions at Cigna, including Chief Operating Officer for the New York/New Jersey Health Plan.

Sturmer received his B.A.

degree in Health Administration from Quinnipiac University.

Non-Employee Directors

Beth Seidenberg, M.D.

has served as a member of our board of directors since May 2010 and as Chair of our board of directors since June 2015.

has served on our board of directors since May 2010 and as Lead Independent Director since January 2022.

Previously, Dr.

Seidenberg served as Chair of our board of directors from June 2015 to December 2021.

Seidenberg has been a partner at Kleiner Perkins, a venture capital firm, since May 2005, where she primarily focuses on life sciences investing.

13 unchanged sentences

Malissia Clinton has served as a member of our board of directors since November 2020.

Clinton has served as Senior Vice President, General Counsel and Secretary at The Aerospace Corporation since 2009.

Clinton has served as Senior Vice President, General Counsel and Secretary at The Aerospace Corporation, a non-profit corporation that provides technical guidance on space missions, since 2009.

She previously worked at Northrop Grumman from 2002 to 2009, including her role as Senior Counsel for Special Projects beginning in 2007.

Clinton joined TRW Space Technology, a division of TRW, Inc., in 1998 as Counsel in its Telecommunication Programs and Avionic Systems division.

Clinton joined TRW Space Technology, a division of TRW, Inc., in 1998 as Counsel in its Telecommunication Programs and Avionic Systems

She began her career as an Associate at Tuttle & Taylor.

1 unchanged sentence

Clinton has served on the board of directors of 3D Systems Corporation since 2019 and on the board of directors of City of Hope Medical Center since 2016.

Clinton holds a Bachelor of Science degree in Political Science and Government from Arizona State University and received her Juris Doctor from the Stanford Law School.

Clinton holds a B.S.

in Political Science and Government from Arizona State University and received her J.D.

from Stanford Law School.

We believe that Ms.

2 unchanged sentences

Cohen is currently a Senior Advisor to TPG Capital, where he previously served for over 15 years as a Partner, and founder of TPG Biotechnology, a life science focused venture capital fund.

Beginning in July 2021, Dr.

Cohen has served as a co-founder and Chairman of Monograph Capital Partners, a biotechnology venture capital fund.

Beginning in November 2017, Dr.

5 unchanged sentences

(since May 2017), CareDx, Inc.

(since January 2003), Intellia Therapeutics, Inc.

(since January 2019) and Veracyte, Inc.

(since 2007).

(since January 2003), and lntellia Therapeutics, Inc.

(since January 2019).

Cohen also serves on the board of directors of several privately-held companies and previously served on the board of directors of BioCryst Pharmaceuticals, Inc.

3 unchanged sentences

from May 2002 until May 2018, Tandem Diabetes Care, Inc.

from June 2013 until June 2019 and Genomic Health Inc.

from April 2002 until November 2019.

from June 2013 until June 2019, Genomic Health Inc.

from April 2002 until November 2019 and Veracyte, Inc.

from 2007 until June 2021.

Cohen received his B.S.

degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil.

in Molecular Biophysics and Biochemistry from Yale University, his D.Phil.

in Molecular Biophysics from Oxford on a Rhodes Scholarship, and his M.D.

1 unchanged sentence

He is a member of the National Academy of Medicine and the American Academy of Arts and Sciences.

Cohen is a California licensed physician.

We believe that Dr.

1 unchanged sentence

Kevin Gordon has served as a member of our board of directors since October 2019.

Gordon has also served on the board of directors of Veracyte, Inc., a genomic diagnostics company, since December 2016, and Q Holdco Limited, a private company that provides world class engineered and elastomeric solutions, since September 2019.

Gordon has also served on the board of directors of Veracyte, Inc., a genomic diagnostics company, since December 2016 and as an advisor to 3i Group’s North American healthcare portfolio companies since January 2022, including currently as a director of privately held Q Holdco Limited, Sanisure, Cirtec Medical Corp.

and ten23 health.

From January 2018 until March 2019, he was the President and Chief Financial Officer of Liquidia Technologies Inc., a clinical biopharmaceutical company.

4 unchanged sentences

Gordon held various senior corporate development positions at Teleflex Incorporated from 1997 to 2007.

From 1992 to 1997, he held various senior positions, including Chief Financial Officer at Package Machinery Company.

From 1984 to 1992, he held senior manager and other various finance positions at KPMG LLP.

Gordon holds a Bachelor of Science degree in Accounting from the University of Connecticut.

Prior thereto he held various senior positions, including Chief Financial Officer, at Package Machinery Company and senior manager and other positions at KPMG LLP.

Gordon holds a B.S.

in Accounting from the University of Connecticut.

We believe that Mr.

1 unchanged sentence

Roger Holstein has served as a member of our board of directors since November 2020.

He has been a Managing Director at Vestar Capital Partners since 2006.

He currently serves on the boards of Quest Analytics, Healthgrades and Veritas Collaborative.

He has been a Managing Director at Vestar Capital Partners, a private equity firm, since 2006.

He currently serves on the boards of Quest Analytics, and Mercury Healthcare.

From 1997 to 2005, Mr.

Holstein served as Chief Executive Officer, President or Director of WebMD and helped establish it as the leading source of healthcare information for consumers and professionals.

Holstein served as Chief Executive Officer, President or Director of WebMD Health Corp., or WebMD, and helped establish it as the leading source of healthcare information for consumers and professionals.

From 1991 to 1996, Mr.

4 unchanged sentences

Louis basketball team in the American Basketball Association.

Holstein holds a Bachelor of Arts degree, with distinction, from Swarthmore College.

We believe Mr.

Holstein holds a B.A.

with distinction, from Swarthmore College.

We believe that Mr.

Holstein is qualified to serve on our board of directors because of his extensive leadership and healthcare experience.

Jeff Park has served as a member of our board of directors since October 2019.

Park has served since April 2019 as the Chairman and Chief Executive Officer of WellDyneRx, an independent pharmacy benefits manager.

Park has served since April 2019 as the Chairman and Chief Executive Officer of WellDyneRx, an independent pharmacy benefits manager and has served as a member of the board of directors for P3 Health Partners since December 2021.

From January 2018 until May 2018, he was the Interim Chief Executive Officer of Diplomat Pharmacy, Inc., or Diplomat, a provider of specialty pharmacy services.

Additionally, from June 2017 to February 2019, he served on the board of directors of Diplomat.

Prior to that, from July 2015 until July 2016, he was the Chief Operating Officer of OptumRX, the entity resulting from the merger of Catamaran Corporation, or Catamaran, and OptumRX, UnitedHealthcare Group’s free-standing pharmacy care services business.

to that, from July 2015 until July 2016, he was the Chief Operating Officer of OptumRX, the entity resulting from the merger of Catamaran Corporation, or Catamaran, and OptumRX, UnitedHealthcare Group’s free-standing pharmacy care services business.

Before the merger, from March 2014 until July 2015, he was Catamaran’s Executive Vice President, Operations, and previously served as Catamaran’s Chief Financial Officer, beginning in 2006.

Park holds a Bachelor of Science degree in Accounting from Brock University.

Park served as a member of the board of directors for Ray Graham Assoc.

Illinois Disability not for profit from January 2010 to June 2016.

Park holds a B.S.

in Accounting from Brock University.

We believe that Mr.

2 unchanged sentences

has served on our board of directors since December 2016.

Payson was co-founder and Chief Executive Officer of Healthsource from 1985 to 1997, Chief Executive Officer of Oxford Health Plans from 1998 to 2002, Chairman of Concentra from 2005 to 2008 and Chief Executive Officer of Apria Healthcare Group Inc.

Payson was co-founder of Healthsource and its Chief Executive Officer from 1985 to 1997, Chief Executive Officer of Oxford Health Plans from 1998 to 2002, Chairman of Concentra from 2005 to 2008 and Chief Executive Officer of Apria Healthcare Group Inc.

from 2008 to 2012, where he is currently a member of the board of directors.

In February of 2021 Apria Healthcare Group, Inc.

completed a public offering and is publicly traded.

Since 1997, Dr.

1 unchanged sentence

Additionally, Dr.

Payson served as a strategic advisor for Evolent Health, Inc., or Evolent, from March 2014 through December 2020 and from December 2013 to June 2019, Dr.

Payson also served on the board of directors of Evolent.

Payson is currently serving on the Board of Directors of various private and not-for-profit companies including Access Clinical Partners, City of Hope, Smile Brands, HPM National Advisory Board at the Mailman School of Public Health at Columbia and USC Schaeffer Center Advisory Board.

Payson served as a strategic advisor for Evolent Health, Inc., or Evolent, from March 2014 through December 2020 and previously served on its board of directors from December 2013 to June 2019.

Payson is currently serving on the board of directors of various private and not-for-profit companies including Access Clinical Partners, Smile Brands, Implantable Provider Group, HPM National Advisory Board at the Mailman School of Public Health at Columbia, USC Schaeffer Center Advisory Board and Executive Services Corporation of Southern California.

Payson is also on the board of Kiva Foundation, a private charitable foundation organized by Dr.

1 unchanged sentence

Until June 2020, Dr.

Payson served on the board for City of Hope, where he now serves as director emeritus.

He continues to serve on the boards of AccessHope and Beckman Research Institute which are subsidiaries of City of Hope.

Until June 2019, Dr.

Payson served as a director at Geisel School of Medicine at Dartmouth, where he now serves as director emeritus.

Payson holds a Bachelor of Science degree in earth and planetary sciences from the Massachusetts Institute of Technology and received his doctorate in medicine from Dartmouth Medical School.

From May 2017 to August 2019 Dr.

Payson was a board member of The Center for Orthopaedic and Research Excellence, Inc.

Payson holds a B.S.

in Earth and Planetary Sciences from the Massachusetts Institute of Technology and received his M.D.

from Dartmouth Medical School.

Payson is a California licensed physician.

2 unchanged sentences

Cheryl Scott has served as a member of our board of directors since October 2019.

Scott has served since July 2016 as the Main Principal of the McClintock Scott Group.

Since July 2016, Ms.

Scott has served as the Main Principal of the McClintock Scott Group.

From June 2006 to July 2016, Ms.

Scott served as

Senior Advisor to the Bill & Melinda Gates Foundation.

Scott served as Senior Advisor to the Bill & Melinda Gates Foundation.

Previously, she served as President and Chief Executive Officer of the Seattle-based Group Health Cooperative for eight years.

Scott has served as a member of the board of directors of Evolent Health, Inc.

since November 2015.

She also currently serves on a variety of private and not-for-profit boards.

Scott has served as a member of the board of directors of Evolent since November 2015.

She also currently serves on a variety of private company and not-for-profit boards.

She was a member of the board of directors of Recreational Equipment Incorporated (REI) from 2005 to 2017, and served as the board chairperson from 2015 to 2017.

Scott received her bachelor’s degree in communications and master’s degree in health management from the University of Washington, and is currently a Clinical Professor of Health Services at the University of Washington.

Scott received her B.A.

in Journalism and M.H.A.

from the University of Washington, and is currently a Clinical Professor of Health Services at the University of Washington.

We believe that Ms.

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 3. Legal Proceedings